Other subjective risk factors (eg, insulin treatment and DM duration) and potential factors that might be associated with the prevalence of DR were not included in our analysis of regional burden of DR in China, which might reduce the reliability of our estimation at the subnational level. This evidence concerns the gene INS and diabetes mellitus.